Mangrove Partners Anebulo Pharmaceuticals, Inc. Transaction History
Mangrove Partners
- $691 Million
- Q2 2025
A detailed history of Mangrove Partners transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, Mangrove Partners holds 2,525,252 shares of ANEB stock, worth $6.44 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
2,525,252
Previous 2,525,252
-0.0%
Holding current value
$6.44 Million
Previous $3.28 Million
10.79%
% of portfolio
0.53%
Previous 0.52%
Shares
5 transactions
Others Institutions Holding ANEB
# of Institutions
19Shares Held
22.2MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA15.5MShares$39.4 Million18.72% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.04MShares$7.74 Million0.19% of portfolio
-
Morgan Stanley New York, NY399KShares$1.02 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA216KShares$550,6750.0% of portfolio
-
Geode Capital Management, LLC Boston, MA206KShares$524,5860.0% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $65.4M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...